TPW Stock Overview Provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Trupanion, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for Trupanion Historical stock prices Current Share Price US$48.40 52 Week High US$52.66 52 Week Low US$18.30 Beta 1.6 1 Month Change -4.27% 3 Month Change 27.60% 1 Year Change 76.97% 3 Year Change -58.04% 5 Year Change 45.78% Change since IPO 472.98%
Recent News & Updates
Third quarter 2024 earnings released: EPS: US$0.034 (vs US$0.097 loss in 3Q 2023) Nov 01
Trupanion, Inc. to Report Q3, 2024 Results on Oct 30, 2024 Oct 15
New minor risk - Profitability Aug 09
Forecast to breakeven in 2025 Aug 09
Second quarter 2024 earnings released: US$0.14 loss per share (vs US$0.33 loss in 2Q 2023) Aug 09
New minor risk - Profitability Aug 06 See more updates
Third quarter 2024 earnings released: EPS: US$0.034 (vs US$0.097 loss in 3Q 2023) Nov 01
Trupanion, Inc. to Report Q3, 2024 Results on Oct 30, 2024 Oct 15
New minor risk - Profitability Aug 09
Forecast to breakeven in 2025 Aug 09
Second quarter 2024 earnings released: US$0.14 loss per share (vs US$0.33 loss in 2Q 2023) Aug 09
New minor risk - Profitability Aug 06
Trupanion, Inc. to Report Q2, 2024 Results on Aug 08, 2024 Jul 19
No longer forecast to breakeven Jun 05
Founder recently bought €464k worth of stock May 14
No longer forecast to breakeven May 05
First quarter 2024 earnings released: US$0.16 loss per share (vs US$0.60 loss in 1Q 2023) May 03 Trupanion, Inc. Announces Chief Executive Officer Changes May 03
Trupanion Introduces truInsights: A Pet Health Data Initiative Apr 24
Trupanion Introduces truInsights: A Pet Health Data Initiative Apr 23
Trupanion, Inc. to Report Q1, 2024 Results on May 02, 2024 Apr 21
Daniel “Dan” Levitan and Zay Satchu, Members of the Board of Directors Will Not Stand for Re-Election of Trupanion, Inc Apr 05
Forecast breakeven date moved forward to 2025 Feb 18
Full year 2023 earnings released: US$1.08 loss per share (vs US$1.10 loss in FY 2022) Feb 16
Trupanion, Inc. to Report Q4, 2023 Results on Feb 15, 2024 Feb 09
Forecast to breakeven in 2026 Dec 31
Insider recently sold €243k worth of stock Dec 05
Trupanion, Inc. Appoints Richard Enthoven as an Independent Director Nov 09
Third quarter 2023 earnings released: US$0.097 loss per share (vs US$0.32 loss in 3Q 2022) Nov 03
Trupanion, Inc. to Report Q3, 2023 Results on Nov 02, 2023 Oct 18
Trupanion, Inc. Announces Appointment of Fawwad Qureshi as Chief Financial Officer on September 25, 2023 Sep 07
Second quarter 2023 earnings released: US$0.33 loss per share (vs US$0.33 loss in 2Q 2022) Aug 04
Trupanion, Inc. to Report Q2, 2023 Results on Aug 03, 2023 Jul 14
Trupanion, Inc. Announces Appointment of Max Brodn as Independent Director Jul 06
First quarter 2023 earnings released: US$0.60 loss per share (vs US$0.22 loss in 1Q 2022) May 06
Independent Director & Consultant recently sold €194k worth of stock Mar 01 Trupanion, Inc. Provides Earnings Guidance for the First Quarter and Full Year of 2023 Feb 18
Full year 2022 earnings released: US$1.10 loss per share (vs US$0.89 loss in FY 2021) Feb 17
Trupanion, Inc. to Report Q4, 2022 Results on Feb 15, 2023 Jan 26 Trupanion, Inc., Annual General Meeting, Jun 07, 2023
Insufficient new directors Nov 16
Third quarter 2022 earnings released: US$0.32 loss per share (vs US$0.17 loss in 3Q 2021) Nov 05
Trupanion, Inc. (NasdaqGM:TRUP) entered into a definitive agreement to acquire PetExpert Europe s.r.o.. Nov 05
Trupanion, Inc. (NasdaqGM:TRUP) has signed a definitive agreement to acquire Royal Blue s.r.o. Nov 04
Trupanion, Inc. to Report Q3, 2022 Results on Nov 03, 2022 Oct 19
Founder recently sold €250k worth of stock Oct 05
Trupanion, Inc. (NasdaqGM:TRUP) acquired Smart Paws GmbH. Sep 08
Insider recently sold €217k worth of stock Aug 27
President recently sold €487k worth of stock Aug 11
Trupanion Appoints Brenna McGibney as Chief People Officer Aug 10
Second quarter 2022 earnings released: US$0.33 loss per share (vs US$0.23 loss in 2Q 2021) Aug 04
Trupanion, Inc. to Report Q2, 2022 Results on Aug 03, 2022 Jul 14 Trupanion, Inc. Announces Management Changes Jun 09
President recently sold €64k worth of stock May 18
First quarter 2022 earnings released: US$0.22 loss per share (vs US$0.31 loss in 1Q 2021) May 01
Insufficient new directors Apr 27
Trupanion, Inc. to Report Q1, 2022 Results on Apr 28, 2022 Apr 15
Trupanion, Inc., Annual General Meeting, Jun 08, 2022 Mar 06
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Feb 17
Trupanion, Inc. Announces Executive Changes Feb 17
Trupanion, Inc. to Report Q4, 2021 Results on Feb 16, 2022 Feb 03
Independent Director & Consultant recently sold €166k worth of stock Nov 13
Third quarter 2021 earnings released: US$0.17 loss per share (vs US$0.072 loss in 3Q 2020) Nov 04
Insufficient new directors Nov 01
Insufficient new directors Oct 02
Second quarter 2021 earnings released: US$0.23 loss per share (vs US$0.038 profit in 2Q 2020) Aug 06
Independent Director H. Hays Lindsley has left the company Jun 22
Independent Director Robin Ferracone has left the company Jun 22
Independent Director recently bought €1.2m worth of stock May 08
First quarter 2021 earnings released: US$0.31 loss per share (vs US$0.032 loss in 1Q 2020) May 01
Robin Ferracone and Hays Lindsley, Each A Member of the Board of Directors of Trupanion, Inc., Notifies to Not Stand for Re-Election Mar 06
New 90-day low: €75.50 Mar 05
Co-President recently sold €421k worth of stock Feb 26
Full year 2020 earnings released: US$0.16 loss per share (vs US$0.052 loss in FY 2019) Feb 12
Revenue beats expectations Feb 12
New 90-day high: €104 Feb 10
Trupanion, Inc. Announces Management Appointments Feb 05
Trupanion, Inc. to Report Q4, 2020 Results on Feb 10, 2021 Jan 28
New 90-day high: €86.50 Dec 16
Insider recently sold €328k worth of stock Dec 03
Trupanion, Inc. Appoints Eric Johnson as a Class II director and Member of the Nominating and Corporate Governance and Compensation Committees Dec 02
Independent Director recently sold €64k worth of stock Nov 22
New 90-day high: €81.00 Nov 19
Independent Chairman recently sold €2.4m worth of stock Nov 05
Third-quarter earnings released: Revenue beats expectations Oct 31
New 90-day high: €77.50 Oct 15
Trupanion, Inc. to Report Q3, 2020 Results on Oct 29, 2020 Oct 14
New 90-day high: €63.00 Sep 28
New 90-day high - €46.20 Aug 05
Trupanion, Inc. to Report Q2, 2020 Results on Aug 04, 2020 Jul 18 Shareholder Returns TPW DE Insurance DE Market 7D 1.6% -0.8% -0.3% 1Y 77.0% 23.6% 7.0%
See full shareholder returns
Return vs Market: TPW exceeded the German Market which returned 7% over the past year.
Price Volatility Is TPW's price volatile compared to industry and market? TPW volatility TPW Average Weekly Movement 6.9% Insurance Industry Average Movement 3.2% Market Average Movement 4.9% 10% most volatile stocks in DE Market 11.6% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: TPW has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: TPW's weekly volatility (7%) has been stable over the past year.
About the Company Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Show more Trupanion, Inc. Fundamentals Summary How do Trupanion's earnings and revenue compare to its market cap? TPW fundamental statistics Market cap €2.07b Earnings (TTM ) -€12.92m Revenue (TTM ) €1.20b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) TPW income statement (TTM ) Revenue US$1.24b Cost of Revenue US$991.44m Gross Profit US$252.80m Other Expenses US$266.25m Earnings -US$13.45m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -0.32 Gross Margin 20.32% Net Profit Margin -1.08% Debt/Equity Ratio 40.3%
How did TPW perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/26 05:27 End of Day Share Price 2024/12/23 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Trupanion, Inc. is covered by 18 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Christopher Merwin Barclays Joshua Shanker BofA Global Research Michael Graham Canaccord Genuity
Show 15 more analysts 
